The Fibroblast Activation Protein Inhibitor (FAPI) market is a hotbed of research and development, characterized by aggressive strategic maneuvering aimed at securing intellectual property and achieving first-mover advantage in a rapidly evolving theranostic space. The R&D focus is primarily twofold: first, the synthesis of novel FAPI ligands with enhanced...